Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48-week data from a randomized, double-blind trial
Authors:
- B ClotetBCB Clotet
- A PlettenbergAPA Plettenberg
- J JostJJJ Jost
- K ArastehKAK Arasteh
- E BernasconiEBE Bernasconi
- V JeantilsVJV Jeantils
- A CutrellACA Cutrell
- C StoneCSC Stone
- S PurdonSPS Purdon
- on behalf of the CNA3002 European Study TeamOTon behalf of the CNA3002 European Study Team
Open Access
- 1 January 2001
- journal article
- clinical trial
- Published by Wiley in HIV Medicine
- Vol. 2 (1) , 27-34
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trialAIDS, 2000
- Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance TherapyJAMA, 2000
- On the numerical integration of multi‐dimensional, initial boundary value problems for the Euler equations in quasi‐linear formNumerical Methods for Partial Differential Equations, 1998
- Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp.Journal of Antimicrobial Chemotherapy, 1998
- Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89Antimicrobial Agents and Chemotherapy, 1997
- Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination TherapyScience, 1995